What question did this study set out to answer?

To assess how frequently thrombophilia screening results alter clinical treatment decisions in patients with and without venous thromboembolism.

December 10, 2024HämostaseologieOpen Access

Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study

View Full Paper

Ask AI

Bookmark

Authors

HMHannah L. McRae JMJens Müller HRHeiko Rühl

Discussion

Member takes

Overview

Retrospective cohort study reveals treatment changes in 22% of screened patients, suggesting pretest probability scores optimize anticoagulation management.

Key Points

To assess how frequently thrombophilia screening results alter clinical treatment decisions in patients with and without venous thromboembolism.
Retrospective cohort study evaluating clinical and laboratory data from 255 patients undergoing thrombophilia screening.
Assessed pretest probability using a local clinical indicator score to stratify patients into clear phenotype, unclassified, or asymptomatic categories.
Thrombophilic risk factors were identified in 98 of 255 patients (38.4%), including 64 of 144 (44.5%) with a clear phenotype and 26 of 83 (31.3%) unclassified patients.
Treatment recommendations changed in 57 of 255 patients (22%) after thrombophilia testing.
Modifications included switching 8 patients from direct oral anticoagulants to vitamin K antagonists for triple-positive antiphospholipid syndrome, increasing anticoagulant dosage in 3 patients, and prolonging treatment in 46 patients.

Cite This Study

McRae et al. (2024) studied this question.

synapsesocial.com/papers/6a820a865feb15765cbf6f2e https://doi.org/10.1055/a-2447-5522

View Full Paper

Ask AI

Bookmark

December 10, 2024HämostaseologieOpen Access

Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study

View Full Paper

Ask AI

Bookmark

Authors

HMHannah L. McRae JMJens Müller HRHeiko Rühl

Discussion

Member takes

Overview

Retrospective cohort study reveals treatment changes in 22% of screened patients, suggesting pretest probability scores optimize anticoagulation management.

Key Points

To assess how frequently thrombophilia screening results alter clinical treatment decisions in patients with and without venous thromboembolism.
Retrospective cohort study evaluating clinical and laboratory data from 255 patients undergoing thrombophilia screening.
Assessed pretest probability using a local clinical indicator score to stratify patients into clear phenotype, unclassified, or asymptomatic categories.
Thrombophilic risk factors were identified in 98 of 255 patients (38.4%), including 64 of 144 (44.5%) with a clear phenotype and 26 of 83 (31.3%) unclassified patients.
Treatment recommendations changed in 57 of 255 patients (22%) after thrombophilia testing.
Modifications included switching 8 patients from direct oral anticoagulants to vitamin K antagonists for triple-positive antiphospholipid syndrome, increasing anticoagulant dosage in 3 patients, and prolonging treatment in 46 patients.

Cite This Study

McRae et al. (2024) studied this question.

synapsesocial.com/papers/6a820a865feb15765cbf6f2e https://doi.org/10.1055/a-2447-5522

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark